Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics.
about
Efficacy of ipragliflozin as monotherapy or as add-on therapy with other oral antidiabetic medications for treating type 2 diabetes in Japanese patients with inadequate glycemic control: A subgroup analysis based on patient characteristics.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy of ipragliflozin as m ...... ed on patient characteristics.
@en
Efficacy of ipragliflozin as m ...... ed on patient characteristics.
@nl
type
label
Efficacy of ipragliflozin as m ...... ed on patient characteristics.
@en
Efficacy of ipragliflozin as m ...... ed on patient characteristics.
@nl
prefLabel
Efficacy of ipragliflozin as m ...... ed on patient characteristics.
@en
Efficacy of ipragliflozin as m ...... ed on patient characteristics.
@nl
P2093
P2860
P356
P1476
Efficacy of ipragliflozin as m ...... sed on patient characteristics
@en
P2093
Atsuko Tamasawa
Hidenori Ishida
Miyoko Saito
Shinya Nakamoto
Yusuke Osonoi
P2860
P304
P356
10.1111/JDI.12705
P577
2017-09-13T00:00:00Z